Daily Mirror - Print Edition

Heart inflammation risk in Pfizer and Moderna jabs evaluated

04 Dec 2021 - {{hitsCtrl.values.hits}}      

 

 

RT.com, 3 Dec, 2021- The European Medicines Agency’s safety committee has confirmed a “very rare” risk of myocarditis and pericarditis in individuals who’ve had the Pfizer-BioNTech or Moderna Covid vaccines, having conducted large Europe-wide studies. The data, released following the latest meeting of the European regulator’s Pharmacovigilance Risk Assessment Committee (PRAC), backed up previous concerns about the potential risk posed by the Covid vaccines.


Both myocarditis and pericarditis are deemed “very rare” in recipients of the Comirnaty jab, produced by Pfizer-BioNTech, and Spikevax, previously known as the Moderna vaccine.


The two conditions were previously added to the side-effects list of the vaccines.


While the research showed there was an increased risk of myocarditis in young males, overall it was assessed that cases are likely to only affect up to one in 10,000 vaccinated individuals.


The two conditions that can develop are both inflammatory conditions of the heart and can result in a range of symptoms, such as breathlessness, irregular heartbeat and chest pain.